The Evolution of 7 Plus 3 Chemotherapy for AML

This chapter explores the historical development of acute myeloid leukemia (AML) treatment, emphasizing the impactful 7 plus 3 chemotherapy regimen introduced in the 1970s. It reviews the progression of chemotherapy drugs, key clinical trials, and the notable improvements in complete remission rates linked to this regimen.